Gilman Hill Asset Management’s Teladoc Health TDOC Stock Holding History

Gilman Hill Asset Management’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-1,000	Closed	-$219K	–	175
2020 Q3	$219K	Sell	1,000 -250	-20%	-$52.9K	0.08%	151
2020 Q2	$239K	Buy	+1,250	New	+$219K	0.1%	142

Other funds holding TDOC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

GCGM

General Catalyst Group Management Cambridge, Massachusetts $184M AUM 50.45% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Gilman Hill Asset Management's TDOC Position: Q4 2020 in Review

Gilman Hill Asset Management sold out of Teladoc Health (TDOC) in Q4 2020, closing a stake of 1,000 shares — an estimated $219K sold.

Gilman Hill Asset Management first reported a position in TDOC in Q2 2020 and held it in 2 quarters. The position peaked at $239K in Q2 2020. 900 funds tracked by Wall St. Rank hold TDOC as of Q4 2020.

Gilman Hill Asset Management reported no remaining Teladoc Health position as of Q4 2020 after selling out during the quarter.
Gilman Hill Asset Management sold 1,000 Teladoc Health shares in Q4 2020, an estimated $219K.
Gilman Hill Asset Management first reported a position in Teladoc Health in Q2 2020 and held it in 2 quarters.
Gilman Hill Asset Management's Teladoc Health position peaked at $239K in Q2 2020.
900 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2020.

Based on Gilman Hill Asset Management's 13F filing for Q4 2020, filed 19 Jan 2021.